Corrigendum—Consent to the Distribution of New Medicines

In the notice with the above heading, published in the New Zealand Gazette, 6 June 2019, Issue No. 2019-go2560, replace the notice with the following:

Schedule

Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:	IPCA-Enalapril Enalapril maleate 5mg Tablet Ipca Pharma (NZ) Pty Limited Ipca Laboratories Limited, Silvassa, India
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:	IPCA-Enalapril Enalapril maleate 10mg Tablet Ipca Pharma (NZ) Pty Limited Ipca Laboratories Limited, Silvassa, India
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:	IPCA-Enalapril Enalapril maleate 20mg Tablet Ipca Pharma (NZ) Pty Limited Ipca Laboratories Limited, Silvassa, India
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:	Lemtrada Alemtuzumab 10mg/mL Concentrate for infusion Sanofi-Aventis New Zealand Limited Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany

Dated this 7th day of June 2019.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).